Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy.
Thorsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD. Thorsen L, et al. Among authors: hornslien k. J Clin Oncol. 2005 Apr 1;23(10):2378-88. doi: 10.1200/JCO.2005.04.106. J Clin Oncol. 2005. PMID: 15800330 Clinical Trial.
Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy.
Thorsen L, Nystad W, Stigum H, Hjermstad M, Oldervoll L, Martinsen EW, Hornslien K, Strømme SB, Dahl AA, Fosså SD. Thorsen L, et al. Among authors: hornslien k. J Sports Med Phys Fitness. 2006 Mar;46(1):122-7. J Sports Med Phys Fitness. 2006. PMID: 16596110
Effectiveness after 1 year of a short-term physical activity intervention on cardiorespiratory fitness in cancer patients.
Thorsen L, Dahl AA, Skovlund E, Hornslien K, Fosså SD. Thorsen L, et al. Among authors: hornslien k. J Clin Oncol. 2007 Apr 1;25(10):1301-2. doi: 10.1200/JCO.2007.10.6682. J Clin Oncol. 2007. PMID: 17401029 Clinical Trial. No abstract available.
Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial.
Sande TA, Ruenes R, Lund JA, Bruland OS, Hornslien K, Bremnes R, Kaasa S. Sande TA, et al. Among authors: hornslien k. Radiother Oncol. 2009 May;91(2):261-6. doi: 10.1016/j.radonc.2009.02.014. Epub 2009 Mar 21. Radiother Oncol. 2009. PMID: 19307034 Clinical Trial.
Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
Grønberg BH, Halvorsen TO, Fløtten Ø, Brustugun OT, Brunsvig PF, Aasebø U, Bremnes RM, Tollåli T, Hornslien K, Aksnessæther BY, Liaaen ED, Sundstrøm S; Norwegian Lung Cancer Study Group. Grønberg BH, et al. Among authors: hornslien k. Acta Oncol. 2016 May;55(5):591-7. doi: 10.3109/0284186X.2015.1092584. Epub 2015 Oct 23. Acta Oncol. 2016. PMID: 26494411 Clinical Trial.
An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients.
Koller M, Hjermstad MJ, Tomaszewski KA, Tomaszewska IM, Hornslien K, Harle A, Arraras JI, Morag O, Pompili C, Ioannidis G, Georgiou M, Navarra C, Chie WC, Johnson CD, Himpel A, Schulz C, Bohrer T, Janssens A, Kuliś D, Bottomley A. Koller M, et al. Among authors: hornslien k. Ann Oncol. 2017 Nov 1;28(11):2874-2881. doi: 10.1093/annonc/mdx453. Ann Oncol. 2017. PMID: 28945875 Free article. Clinical Trial.
Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group.
Fløtten Ø, Grønberg BH, Bremnes R, Amundsen T, Sundstrøm S, Rolke H, Hornslien K, Wentzel-Larsen T, Aasebø U, von Plessen C. Fløtten Ø, et al. Among authors: hornslien k. Br J Cancer. 2012 Jul 24;107(3):442-7. doi: 10.1038/bjc.2012.284. Epub 2012 Jul 3. Br J Cancer. 2012. PMID: 22759880 Free PMC article. Clinical Trial.
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Halvorsen TO, Stokke K, Killingberg KT, Raj SX, Sørhaug S, Brustugun OT, Fløtten Ø, Helbekkmo N, Hornslien K, Madebo T, Fluge S, Grønberg BH. Halvorsen TO, et al. Among authors: hornslien k. Acta Oncol. 2020 Jun 16:1-7. doi: 10.1080/0284186X.2020.1778179. Online ahead of print. Acta Oncol. 2020. PMID: 32543258
Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival.
Strand TE, Brunsvig PF, Johannessen DC, Sundstrøm S, Wang M, Hornslien K, Bremnes RM, Stensvold A, Garpestad O, Norstein J. Strand TE, et al. Among authors: hornslien k. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):133-41. doi: 10.1016/j.ijrobp.2010.01.050. Epub 2010 May 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20452137
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; EORTC Lung Cancer Group; European Society of Thoracic Surgeons. Koller M, et al. Among authors: hornslien k. Lancet Oncol. 2020 May;21(5):723-732. doi: 10.1016/S1470-2045(20)30093-0. Epub 2020 Mar 23. Lancet Oncol. 2020. PMID: 32213338 Clinical Trial.
16 results
Jump to page
Feedback